P-tau217 as a Reliable Blood-Based Marker of Alzheimer’s Disease
Amyloid plaques and tau tangles are the hallmark pathologic features of Alzheimer’s disease (AD). Traditionally, these changes are identified in vivo via cerebrospinal fluid (CSF) analysis or positron emission tomography (PET) scans. However, these methods are invasive, expensive, and resource-inten...
| Published in: | Biomedicines |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-08-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/12/8/1836 |